The following documents are filed as exhibits to this Report.
EXHIBIT INDEX
| Exhibit No. | Description |
| 3.1 | Amended and Restated Certificate of Incorporation filed with Delaware Secretary of State on February 23, 2022.(1) |
| 3.2 | Certificate of Amendment to the Company’s Second Amended and Restated Certificate of Incorporation(2) |
| 3.3 | Certificate of Amendment to the Company’s Second Amended and Restated Certificate of Incorporation.(3) |
| 3.4 | Fourth Amended and Restated Bylaws of the Company.(3) |
| 10.1 | Release, dated January 10, 2024, between the Company and Dr. Neil Campbell.(4) |
| 10.2 | Separation Agreement, dated January 17, 2024, between the Company and Erin Henderson.(5) |
| 10.3 | Consulting Agreement, dated January 17, 2024, between the Company and The Aetos Group.(5) |
| 10.4 | Debenture, dated January 23, 2024.(6) |
| 10.5 | Consulting Agreement, dated January 4, 2024, between Proteomedix and Thomas Meier.(7) |
| 10.6 | Forbearance Agreement, dated April 24, 2024, between the Company and Veru(8) |
| 10.7 | Amendment to Non-Convertible Debenture, dated April 24, 2024, between the Company and Altos(8) |
| 31.1* | Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 31.2* | Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 32.1** | Certification of the Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| 32.2** | Certification of the Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| 101.INS* | Inline XBRL Instance Document. |
| 101.SCH* | Inline XBRL Taxonomy Extension Schema Document. |
| 101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| 101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase Document. |
| 101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
| (1) | Incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on February 24, 2022. |
| (2) | Incorporated by reference to the Company’s Current Report on Form 8-K, filed with the SEC on April 24, 2023. |
| (3) | Incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on December 21, 2023. |
| (4) | Incorporated by reference to the Company’s Current Report on Form 8-K, filed with the SEC on January 12, 2024. |
| (5) | Incorporated by reference the Company’s Current Report on Form 8-K, filed with the SEC on January 19, 2024. |
| (6) | Incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on January 29, 2024. |
| (7) | Incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on February 12, 2024. |
| (8) | Incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on April 26, 2024. |
